109 results
Page 2 of 6
424B5
g7vlrivk
27 Jul 23
Prospectus supplement for primary offering
5:28pm
8-K
2x47gz1p8m2
26 Jul 23
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
7:42am
8-K
EX-99.1
9ay1o10davl
26 Jul 23
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
7:42am
8-K
EX-99.1
08y5dzl
9 May 23
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
8:35am
8-K
EX-10.2
nqqe8hagmcz41 9hc3
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-10.1
wykef
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-99.1
obmgagkwee025bpsfx
10 Nov 22
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
8:35am
8-K
EX-99.1
wetrmnxcsiminv6
15 Aug 22
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
7:36am
8-K
hcje94wyy05acml95sp
19 Jul 22
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
u3nmezu1e99hh7t0 bn
19 Jul 22
Regulation FD Disclosure
4:36pm